| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| muscle organ morphogenesis | 3 out of 42 genes, 7.1% | 3 out of 533 genes, 0.6% | 0.000457467 |
| cardiac muscle tissue development | 3 out of 42 genes, 7.1% | 3 out of 533 genes, 0.6% | 0.000457467 |
| cardiac muscle tissue morphogenesis | 3 out of 42 genes, 7.1% | 3 out of 533 genes, 0.6% | 0.000457467 |
| muscle tissue morphogenesis | 3 out of 42 genes, 7.1% | 3 out of 533 genes, 0.6% | 0.000457467 |
| heart morphogenesis | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| circulatory system process | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| heart process | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| blood circulation | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| myofibril assembly | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| actomyosin structure organization | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| actin-myosin filament sliding | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| heart contraction | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| actin-mediated cell contraction | 3 out of 42 genes, 7.1% | 4 out of 533 genes, 0.8% | 0.00172888 |
| muscle cell differentiation | 4 out of 42 genes, 9.5% | 9 out of 533 genes, 1.7% | 0.003157012 |
| single-organism process | 35 out of 42 genes, 83.3% | 341 out of 533 genes, 64.0% | 0.003800098 |
| muscle system process | 3 out of 42 genes, 7.1% | 5 out of 533 genes, 0.9% | 0.004084239 |
| muscle contraction | 3 out of 42 genes, 7.1% | 5 out of 533 genes, 0.9% | 0.004084239 |
| striated muscle tissue development | 3 out of 42 genes, 7.1% | 5 out of 533 genes, 0.9% | 0.004084239 |
| muscle cell development | 3 out of 42 genes, 7.1% | 5 out of 533 genes, 0.9% | 0.004084239 |
| striated muscle cell development | 3 out of 42 genes, 7.1% | 5 out of 533 genes, 0.9% | 0.004084239 |
| muscle tissue development | 3 out of 42 genes, 7.1% | 5 out of 533 genes, 0.9% | 0.004084239 |
| striated muscle contraction | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| regulation of blood pressure | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| skeletal myofibril assembly | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| skeletal muscle thin filament assembly | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| cardiocyte differentiation | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| cardiac myofibril assembly | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| cardiac cell development | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| cardiac muscle cell differentiation | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| cardiac muscle cell development | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| cardiac muscle contraction | 2 out of 42 genes, 4.8% | 2 out of 533 genes, 0.4% | 0.006072874 |
| single-organism cellular process | 33 out of 42 genes, 78.6% | 320 out of 533 genes, 60.0% | 0.006920632 |
| muscle structure development | 4 out of 42 genes, 9.5% | 11 out of 533 genes, 2.1% | 0.007350772 |
| muscle organ development | 3 out of 42 genes, 7.1% | 6 out of 533 genes, 1.1% | 0.007719878 |
| actin filament-based movement | 3 out of 42 genes, 7.1% | 6 out of 533 genes, 1.1% | 0.007719878 |
| cellular component organization | 21 out of 42 genes, 50.0% | 169 out of 533 genes, 31.7% | 0.007811843 |
| cellular component assembly involved in morphogenesis | 3 out of 42 genes, 7.1% | 7 out of 533 genes, 1.3% | 0.01276976 |
| regulation of actin filament depolymerization | 3 out of 42 genes, 7.1% | 7 out of 533 genes, 1.3% | 0.01276976 |
| striated muscle cell differentiation | 3 out of 42 genes, 7.1% | 7 out of 533 genes, 1.3% | 0.01276976 |
| regulation of anatomical structure size | 4 out of 42 genes, 9.5% | 13 out of 533 genes, 2.4% | 0.01416365 |
| response to temperature stimulus | 2 out of 42 genes, 4.8% | 3 out of 533 genes, 0.6% | 0.01730369 |
| response to heat | 2 out of 42 genes, 4.8% | 3 out of 533 genes, 0.6% | 0.01730369 |
| muscle filament sliding | 2 out of 42 genes, 4.8% | 3 out of 533 genes, 0.6% | 0.01730369 |
| lipoprotein metabolic process | 2 out of 42 genes, 4.8% | 3 out of 533 genes, 0.6% | 0.01730369 |
| skeletal muscle fiber development | 2 out of 42 genes, 4.8% | 3 out of 533 genes, 0.6% | 0.01730369 |
| muscle fiber development | 2 out of 42 genes, 4.8% | 3 out of 533 genes, 0.6% | 0.01730369 |
| cellular component organization or biogenesis | 21 out of 42 genes, 50.0% | 180 out of 533 genes, 33.8% | 0.01754967 |
| regulation of protein depolymerization | 3 out of 42 genes, 7.1% | 8 out of 533 genes, 1.5% | 0.0193154 |
| cell adhesion | 6 out of 42 genes, 14.3% | 30 out of 533 genes, 5.6% | 0.02357562 |
| biological adhesion | 6 out of 42 genes, 14.3% | 30 out of 533 genes, 5.6% | 0.02357562 |
| heart development | 3 out of 42 genes, 7.1% | 9 out of 533 genes, 1.7% | 0.0273946 |
| regulation of protein complex disassembly | 3 out of 42 genes, 7.1% | 9 out of 533 genes, 1.7% | 0.0273946 |
| tissue morphogenesis | 3 out of 42 genes, 7.1% | 9 out of 533 genes, 1.7% | 0.0273946 |
| cellular process involved in reproduction | 6 out of 42 genes, 14.3% | 32 out of 533 genes, 6.0% | 0.0318845 |
| skeletal muscle tissue development | 2 out of 42 genes, 4.8% | 4 out of 533 genes, 0.8% | 0.0328785 |
| ribosomal small subunit biogenesis | 2 out of 42 genes, 4.8% | 4 out of 533 genes, 0.8% | 0.0328785 |
| skeletal muscle organ development | 2 out of 42 genes, 4.8% | 4 out of 533 genes, 0.8% | 0.0328785 |
| regulation of actin polymerization or depolymerization | 3 out of 42 genes, 7.1% | 10 out of 533 genes, 1.9% | 0.03700902 |
| regulation of actin filament length | 3 out of 42 genes, 7.1% | 10 out of 533 genes, 1.9% | 0.03700902 |
| tissue development | 4 out of 42 genes, 9.5% | 17 out of 533 genes, 3.2% | 0.03732522 |
| regulation of biological quality | 10 out of 42 genes, 23.8% | 71 out of 533 genes, 13.3% | 0.03903276 |
| protein targeting to membrane | 5 out of 42 genes, 11.9% | 26 out of 533 genes, 4.9% | 0.04518479 |
| macromolecule localization | 12 out of 42 genes, 28.6% | 94 out of 533 genes, 17.6% | 0.04757104 |
| cellular component movement | 6 out of 42 genes, 14.3% | 35 out of 533 genes, 6.6% | 0.04765067 |
| extracellular matrix organization | 3 out of 42 genes, 7.1% | 11 out of 533 genes, 2.1% | 0.04813086 |
| regulation of actin cytoskeleton organization | 3 out of 42 genes, 7.1% | 11 out of 533 genes, 2.1% | 0.04813086 |
| regulation of actin filament-based process | 3 out of 42 genes, 7.1% | 11 out of 533 genes, 2.1% | 0.04813086 |
| extracellular structure organization | 3 out of 42 genes, 7.1% | 11 out of 533 genes, 2.1% | 0.04813086 |
| organic substance transport | 11 out of 42 genes, 26.2% | 84 out of 533 genes, 15.8% | 0.04937472 |
| regulation of muscle contraction | 2 out of 42 genes, 4.8% | 5 out of 533 genes, 0.9% | 0.05207467 |
| actin filament organization | 2 out of 42 genes, 4.8% | 5 out of 533 genes, 0.9% | 0.05207467 |
| steroid metabolic process | 2 out of 42 genes, 4.8% | 5 out of 533 genes, 0.9% | 0.05207467 |
| response to extracellular stimulus | 2 out of 42 genes, 4.8% | 5 out of 533 genes, 0.9% | 0.05207467 |
| cell growth | 2 out of 42 genes, 4.8% | 5 out of 533 genes, 0.9% | 0.05207467 |
| positive regulation of cytoskeleton organization | 2 out of 42 genes, 4.8% | 5 out of 533 genes, 0.9% | 0.05207467 |
| response to stimulus | 19 out of 42 genes, 45.2% | 175 out of 533 genes, 32.8% | 0.05567904 |
| cellular component disassembly | 5 out of 42 genes, 11.9% | 28 out of 533 genes, 5.3% | 0.05994102 |
| regulation of cellular component size | 3 out of 42 genes, 7.1% | 12 out of 533 genes, 2.3% | 0.06070863 |
| cell development | 5 out of 42 genes, 11.9% | 29 out of 533 genes, 5.4% | 0.06825462 |
| ATP catabolic process | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| lipid transport | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| response to virus | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| lipid localization | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| negative regulation of actin filament depolymerization | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| negative regulation of actin filament polymerization | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| actin filament capping | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| regulation of muscle system process | 2 out of 42 genes, 4.8% | 6 out of 533 genes, 1.1% | 0.07425207 |
| translational termination | 4 out of 42 genes, 9.5% | 21 out of 533 genes, 3.9% | 0.07442764 |
| response to abiotic stimulus | 4 out of 42 genes, 9.5% | 21 out of 533 genes, 3.9% | 0.07442764 |
| viral genome expression | 4 out of 42 genes, 9.5% | 21 out of 533 genes, 3.9% | 0.07442764 |
| viral transcription | 4 out of 42 genes, 9.5% | 21 out of 533 genes, 3.9% | 0.07442764 |
| nucleocytoplasmic transport | 3 out of 42 genes, 7.1% | 13 out of 533 genes, 2.4% | 0.07467213 |
| organ morphogenesis | 3 out of 42 genes, 7.1% | 13 out of 533 genes, 2.4% | 0.07467213 |
| nuclear transport | 3 out of 42 genes, 7.1% | 13 out of 533 genes, 2.4% | 0.07467213 |
| protein complex disassembly | 4 out of 42 genes, 9.5% | 22 out of 533 genes, 4.1% | 0.08586472 |
| cellular protein complex disassembly | 4 out of 42 genes, 9.5% | 22 out of 533 genes, 4.1% | 0.08586472 |
| localization | 16 out of 42 genes, 38.1% | 148 out of 533 genes, 27.8% | 0.0866404 |
| response to organic cyclic compound | 3 out of 42 genes, 7.1% | 14 out of 533 genes, 2.6% | 0.08993677 |
| cardiovascular system development | 3 out of 42 genes, 7.1% | 14 out of 533 genes, 2.6% | 0.08993677 |
| circulatory system development | 3 out of 42 genes, 7.1% | 14 out of 533 genes, 2.6% | 0.08993677 |
| protein complex subunit organization | 8 out of 42 genes, 19.0% | 61 out of 533 genes, 11.4% | 0.09214705 |
| macromolecular complex subunit organization | 10 out of 42 genes, 23.8% | 82 out of 533 genes, 15.4% | 0.09219552 |
| protein transport | 9 out of 42 genes, 21.4% | 72 out of 533 genes, 13.5% | 0.09629094 |
| viral infectious cycle | 4 out of 42 genes, 9.5% | 23 out of 533 genes, 4.3% | 0.09812285 |
| macromolecular complex disassembly | 4 out of 42 genes, 9.5% | 23 out of 533 genes, 4.3% | 0.09812285 |
| negative regulation of protein polymerization | 2 out of 42 genes, 4.8% | 7 out of 533 genes, 1.3% | 0.09884499 |
| negative regulation of protein complex disassembly | 2 out of 42 genes, 4.8% | 7 out of 533 genes, 1.3% | 0.09884499 |
| response to steroid hormone stimulus | 2 out of 42 genes, 4.8% | 7 out of 533 genes, 1.3% | 0.09884499 |
| organelle assembly | 2 out of 42 genes, 4.8% | 7 out of 533 genes, 1.3% | 0.09884499 |
| negative regulation of protein depolymerization | 2 out of 42 genes, 4.8% | 7 out of 533 genes, 1.3% | 0.09884499 |
| single-organism transport | 11 out of 42 genes, 26.2% | 94 out of 533 genes, 17.6% | 0.09946037 |
| establishment of protein localization | 9 out of 42 genes, 21.4% | 73 out of 533 genes, 13.7% | 0.1032951 |
| protein localization | 10 out of 42 genes, 23.8% | 84 out of 533 genes, 15.8% | 0.1052264 |
| actin cytoskeleton organization | 3 out of 42 genes, 7.1% | 15 out of 533 genes, 2.8% | 0.1064073 |
| cotranslational protein targeting to membrane | 4 out of 42 genes, 9.5% | 24 out of 533 genes, 4.5% | 0.1111694 |
| SRP-dependent cotranslational protein targeting to membrane | 4 out of 42 genes, 9.5% | 24 out of 533 genes, 4.5% | 0.1111694 |
| response to external stimulus | 4 out of 42 genes, 9.5% | 24 out of 533 genes, 4.5% | 0.1111694 |
| protein targeting to ER | 4 out of 42 genes, 9.5% | 24 out of 533 genes, 4.5% | 0.1111694 |
| protein localization to endoplasmic reticulum | 4 out of 42 genes, 9.5% | 24 out of 533 genes, 4.5% | 0.1111694 |
| establishment of protein localization to endoplasmic reticulum | 4 out of 42 genes, 9.5% | 24 out of 533 genes, 4.5% | 0.1111694 |
| multi-organism process | 7 out of 42 genes, 16.7% | 54 out of 533 genes, 10.1% | 0.1188754 |
| regulation of cytoskeleton organization | 3 out of 42 genes, 7.1% | 16 out of 533 genes, 3.0% | 0.1239809 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4 out of 42 genes, 9.5% | 25 out of 533 genes, 4.7% | 0.1249665 |
| cellular component morphogenesis | 4 out of 42 genes, 9.5% | 25 out of 533 genes, 4.7% | 0.1249665 |
| negative regulation of protein complex assembly | 2 out of 42 genes, 4.8% | 8 out of 533 genes, 1.5% | 0.1253549 |
| growth | 2 out of 42 genes, 4.8% | 8 out of 533 genes, 1.5% | 0.1253549 |
| monosaccharide catabolic process | 2 out of 42 genes, 4.8% | 8 out of 533 genes, 1.5% | 0.1253549 |
| nuclear export | 2 out of 42 genes, 4.8% | 8 out of 533 genes, 1.5% | 0.1253549 |
| negative regulation of cytoskeleton organization | 2 out of 42 genes, 4.8% | 8 out of 533 genes, 1.5% | 0.1253549 |
| nucleic acid phosphodiester bond hydrolysis | 2 out of 42 genes, 4.8% | 8 out of 533 genes, 1.5% | 0.1253549 |
| transport | 14 out of 42 genes, 33.3% | 132 out of 533 genes, 24.8% | 0.1255565 |
| reproduction | 7 out of 42 genes, 16.7% | 55 out of 533 genes, 10.3% | 0.1281944 |
| establishment of localization | 14 out of 42 genes, 33.3% | 133 out of 533 genes, 25.0% | 0.1319697 |
| cell differentiation | 7 out of 42 genes, 16.7% | 56 out of 533 genes, 10.5% | 0.1378885 |
| negative regulation of organelle organization | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| carbohydrate catabolic process | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| regulation of Wnt receptor signaling pathway | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| regulation of actin filament polymerization | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| response to lipid | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| single-organism carbohydrate catabolic process | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| ATP metabolic process | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| response to other organism | 2 out of 42 genes, 4.8% | 9 out of 533 genes, 1.7% | 0.1533435 |
| nuclear-transcribed mRNA catabolic process | 4 out of 42 genes, 9.5% | 27 out of 533 genes, 5.1% | 0.1546411 |
| establishment of protein localization to organelle | 4 out of 42 genes, 9.5% | 27 out of 533 genes, 5.1% | 0.1546411 |
| RNA biosynthetic process | 5 out of 42 genes, 11.9% | 37 out of 533 genes, 6.9% | 0.1562376 |
| RNA catabolic process | 4 out of 42 genes, 9.5% | 28 out of 533 genes, 5.3% | 0.1704244 |
| mRNA catabolic process | 4 out of 42 genes, 9.5% | 28 out of 533 genes, 5.3% | 0.1704244 |
| translational initiation | 4 out of 42 genes, 9.5% | 28 out of 533 genes, 5.3% | 0.1704244 |
| actin filament-based process | 3 out of 42 genes, 7.1% | 19 out of 533 genes, 3.6% | 0.182233 |
| response to biotic stimulus | 2 out of 42 genes, 4.8% | 10 out of 533 genes, 1.9% | 0.1824271 |
| positive regulation of organelle organization | 2 out of 42 genes, 4.8% | 10 out of 533 genes, 1.9% | 0.1824271 |
| regulation of protein polymerization | 2 out of 42 genes, 4.8% | 10 out of 533 genes, 1.9% | 0.1824271 |
| positive regulation of cell differentiation | 2 out of 42 genes, 4.8% | 10 out of 533 genes, 1.9% | 0.1824271 |
| protein targeting | 5 out of 42 genes, 11.9% | 39 out of 533 genes, 7.3% | 0.1835443 |
| cytoplasmic transport | 6 out of 42 genes, 14.3% | 50 out of 533 genes, 9.4% | 0.189579 |
| reproductive process | 6 out of 42 genes, 14.3% | 50 out of 533 genes, 9.4% | 0.189579 |
| cellular developmental process | 7 out of 42 genes, 16.7% | 61 out of 533 genes, 11.4% | 0.1916454 |
| cellular response to stress | 5 out of 42 genes, 11.9% | 40 out of 533 genes, 7.5% | 0.1978545 |
| intracellular protein transport | 6 out of 42 genes, 14.3% | 51 out of 533 genes, 9.6% | 0.2024247 |
| system process | 3 out of 42 genes, 7.1% | 20 out of 533 genes, 3.8% | 0.2031262 |
| anatomical structure formation involved in morphogenesis | 3 out of 42 genes, 7.1% | 20 out of 533 genes, 3.8% | 0.2031262 |
| rRNA processing | 2 out of 42 genes, 4.8% | 11 out of 533 genes, 2.1% | 0.2122707 |
| rRNA metabolic process | 2 out of 42 genes, 4.8% | 11 out of 533 genes, 2.1% | 0.2122707 |
| sexual reproduction | 2 out of 42 genes, 4.8% | 11 out of 533 genes, 2.1% | 0.2122707 |
| positive regulation of multicellular organismal process | 2 out of 42 genes, 4.8% | 11 out of 533 genes, 2.1% | 0.2122707 |
| DNA conformation change | 2 out of 42 genes, 4.8% | 11 out of 533 genes, 2.1% | 0.2122707 |
| cellular process | 38 out of 42 genes, 90.5% | 453 out of 533 genes, 85.0% | 0.2130075 |
| lipid metabolic process | 3 out of 42 genes, 7.1% | 21 out of 533 genes, 3.9% | 0.2245759 |
| viral reproduction | 5 out of 42 genes, 11.9% | 42 out of 533 genes, 7.9% | 0.2276327 |
| multi-organism cellular process | 5 out of 42 genes, 11.9% | 42 out of 533 genes, 7.9% | 0.2276327 |
| response to stress | 8 out of 42 genes, 19.0% | 76 out of 533 genes, 14.3% | 0.2360947 |
| positive regulation of developmental process | 2 out of 42 genes, 4.8% | 12 out of 533 genes, 2.3% | 0.2425832 |
| regulation of organelle organization | 3 out of 42 genes, 7.1% | 22 out of 533 genes, 4.1% | 0.2464777 |
| single organism reproductive process | 2 out of 42 genes, 4.8% | 13 out of 533 genes, 2.4% | 0.2731124 |
| organelle organization | 8 out of 42 genes, 19.0% | 80 out of 533 genes, 15.0% | 0.2845339 |
| regulation of cellular component organization | 5 out of 42 genes, 11.9% | 46 out of 533 genes, 8.6% | 0.2908902 |
| small GTPase mediated signal transduction | 3 out of 42 genes, 7.1% | 24 out of 533 genes, 4.5% | 0.2912397 |
| regulation of cell differentiation | 3 out of 42 genes, 7.1% | 24 out of 533 genes, 4.5% | 0.2912397 |
| protein localization to organelle | 4 out of 42 genes, 9.5% | 36 out of 533 genes, 6.8% | 0.3125184 |
| translational elongation | 3 out of 42 genes, 7.1% | 25 out of 533 genes, 4.7% | 0.3139134 |
| cellular protein localization | 6 out of 42 genes, 14.3% | 60 out of 533 genes, 11.3% | 0.3302453 |
| cellular macromolecule localization | 6 out of 42 genes, 14.3% | 60 out of 533 genes, 11.3% | 0.3302453 |
| viral reproductive process | 4 out of 42 genes, 9.5% | 37 out of 533 genes, 6.9% | 0.3314615 |
| regulation of developmental process | 4 out of 42 genes, 9.5% | 37 out of 533 genes, 6.9% | 0.3314615 |
| response to chemical stimulus | 7 out of 42 genes, 16.7% | 72 out of 533 genes, 13.5% | 0.333856 |
| monosaccharide metabolic process | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| regulation of cell migration | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| ncRNA processing | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| regulation of locomotion | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| regulation of protein complex assembly | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| regulation of system process | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| negative regulation of cellular component organization | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| regulation of cell motility | 2 out of 42 genes, 4.8% | 15 out of 533 genes, 2.8% | 0.3339855 |
| regulation of multicellular organismal process | 5 out of 42 genes, 11.9% | 49 out of 533 genes, 9.2% | 0.3404995 |
| cellular response to stimulus | 12 out of 42 genes, 28.6% | 133 out of 533 genes, 25.0% | 0.3442907 |
| multi-organism reproductive process | 4 out of 42 genes, 9.5% | 38 out of 533 genes, 7.1% | 0.3504968 |
| intracellular signal transduction | 5 out of 42 genes, 11.9% | 50 out of 533 genes, 9.4% | 0.3572684 |
| cell projection organization | 3 out of 42 genes, 7.1% | 27 out of 533 genes, 5.1% | 0.3594197 |
| response to oxygen-containing compound | 3 out of 42 genes, 7.1% | 27 out of 533 genes, 5.1% | 0.3594197 |
| organic cyclic compound biosynthetic process | 6 out of 42 genes, 14.3% | 62 out of 533 genes, 11.6% | 0.3605791 |
| anatomical structure development | 7 out of 42 genes, 16.7% | 74 out of 533 genes, 13.9% | 0.3619004 |
| response to hormone stimulus | 2 out of 42 genes, 4.8% | 16 out of 533 genes, 3.0% | 0.3639861 |
| cell motility | 2 out of 42 genes, 4.8% | 16 out of 533 genes, 3.0% | 0.3639861 |
| regulation of cellular component movement | 2 out of 42 genes, 4.8% | 16 out of 533 genes, 3.0% | 0.3639861 |
| localization of cell | 2 out of 42 genes, 4.8% | 16 out of 533 genes, 3.0% | 0.3639861 |
| anatomical structure morphogenesis | 4 out of 42 genes, 9.5% | 39 out of 533 genes, 7.3% | 0.369577 |
| translation | 5 out of 42 genes, 11.9% | 51 out of 533 genes, 9.6% | 0.3740993 |
| macromolecule catabolic process | 6 out of 42 genes, 14.3% | 63 out of 533 genes, 11.8% | 0.3758626 |
| cytoskeleton organization | 3 out of 42 genes, 7.1% | 28 out of 533 genes, 5.3% | 0.3820992 |
| response to endogenous stimulus | 3 out of 42 genes, 7.1% | 28 out of 533 genes, 5.3% | 0.3820992 |
| locomotion | 3 out of 42 genes, 7.1% | 28 out of 533 genes, 5.3% | 0.3820992 |
| RNA metabolic process | 8 out of 42 genes, 19.0% | 88 out of 533 genes, 16.5% | 0.3885361 |
| apoptotic process | 2 out of 42 genes, 4.8% | 17 out of 533 genes, 3.2% | 0.3935109 |
| chemotaxis | 2 out of 42 genes, 4.8% | 17 out of 533 genes, 3.2% | 0.3935109 |
| programmed cell death | 2 out of 42 genes, 4.8% | 17 out of 533 genes, 3.2% | 0.3935109 |
| taxis | 2 out of 42 genes, 4.8% | 17 out of 533 genes, 3.2% | 0.3935109 |
| regulation of cellular component biogenesis | 2 out of 42 genes, 4.8% | 17 out of 533 genes, 3.2% | 0.3935109 |
| chemical homeostasis | 2 out of 42 genes, 4.8% | 17 out of 533 genes, 3.2% | 0.3935109 |
| single-organism developmental process | 6 out of 42 genes, 14.3% | 65 out of 533 genes, 12.2% | 0.4065442 |
| response to organic substance | 5 out of 42 genes, 11.9% | 53 out of 533 genes, 9.9% | 0.4078219 |
| intracellular transport | 7 out of 42 genes, 16.7% | 78 out of 533 genes, 14.6% | 0.4187268 |
| catabolic process | 10 out of 42 genes, 23.8% | 115 out of 533 genes, 21.6% | 0.4201527 |
| mRNA metabolic process | 6 out of 42 genes, 14.3% | 66 out of 533 genes, 12.4% | 0.4218964 |
| nucleobase-containing compound catabolic process | 6 out of 42 genes, 14.3% | 66 out of 533 genes, 12.4% | 0.4218964 |
| protein folding | 2 out of 42 genes, 4.8% | 18 out of 533 genes, 3.4% | 0.4224493 |
| cell death | 2 out of 42 genes, 4.8% | 18 out of 533 genes, 3.4% | 0.4224493 |
| death | 2 out of 42 genes, 4.8% | 18 out of 533 genes, 3.4% | 0.4224493 |
| ribosome biogenesis | 2 out of 42 genes, 4.8% | 18 out of 533 genes, 3.4% | 0.4224493 |
| positive regulation of cellular component organization | 2 out of 42 genes, 4.8% | 18 out of 533 genes, 3.4% | 0.4224493 |
| homeostatic process | 3 out of 42 genes, 7.1% | 30 out of 533 genes, 5.6% | 0.4269711 |
| positive regulation of biological process | 10 out of 42 genes, 23.8% | 116 out of 533 genes, 21.8% | 0.4323655 |
| macromolecule biosynthetic process | 7 out of 42 genes, 16.7% | 79 out of 533 genes, 14.8% | 0.4329789 |
| cellular macromolecule biosynthetic process | 7 out of 42 genes, 16.7% | 79 out of 533 genes, 14.8% | 0.4329789 |
| biological regulation | 23 out of 42 genes, 54.8% | 279 out of 533 genes, 52.3% | 0.4350989 |
| cellular catabolic process | 9 out of 42 genes, 21.4% | 104 out of 533 genes, 19.5% | 0.437196 |
| aromatic compound catabolic process | 6 out of 42 genes, 14.3% | 67 out of 533 genes, 12.6% | 0.4372265 |
| nucleobase-containing compound biosynthetic process | 5 out of 42 genes, 11.9% | 55 out of 533 genes, 10.3% | 0.441428 |
| organ development | 3 out of 42 genes, 7.1% | 31 out of 533 genes, 5.8% | 0.4490451 |
| single-organism carbohydrate metabolic process | 2 out of 42 genes, 4.8% | 19 out of 533 genes, 3.6% | 0.45071 |
| cellular response to oxygen-containing compound | 2 out of 42 genes, 4.8% | 19 out of 533 genes, 3.6% | 0.45071 |
| positive regulation of cellular process | 9 out of 42 genes, 21.4% | 106 out of 533 genes, 19.9% | 0.4626909 |
| establishment of localization in cell | 7 out of 42 genes, 16.7% | 82 out of 533 genes, 15.4% | 0.4755611 |
| positive regulation of phosphorylation | 2 out of 42 genes, 4.8% | 20 out of 533 genes, 3.8% | 0.4782193 |
| response to nitrogen compound | 2 out of 42 genes, 4.8% | 20 out of 533 genes, 3.8% | 0.4782193 |
| cellular nitrogen compound catabolic process | 6 out of 42 genes, 14.3% | 70 out of 533 genes, 13.1% | 0.4828739 |
| heterocycle catabolic process | 6 out of 42 genes, 14.3% | 70 out of 533 genes, 13.1% | 0.4828739 |
| organic cyclic compound catabolic process | 6 out of 42 genes, 14.3% | 70 out of 533 genes, 13.1% | 0.4828739 |
| aromatic compound biosynthetic process | 5 out of 42 genes, 11.9% | 58 out of 533 genes, 10.9% | 0.4911415 |
| regulation of response to stimulus | 6 out of 42 genes, 14.3% | 71 out of 533 genes, 13.3% | 0.4979091 |
| ncRNA metabolic process | 2 out of 42 genes, 4.8% | 21 out of 533 genes, 3.9% | 0.5049186 |
| heterocycle biosynthetic process | 5 out of 42 genes, 11.9% | 59 out of 533 genes, 11.1% | 0.5074284 |
| cellular macromolecule catabolic process | 5 out of 42 genes, 11.9% | 59 out of 533 genes, 11.1% | 0.5074284 |
| cellular nitrogen compound biosynthetic process | 5 out of 42 genes, 11.9% | 59 out of 533 genes, 11.1% | 0.5074284 |
| positive regulation of catalytic activity | 3 out of 42 genes, 7.1% | 34 out of 533 genes, 6.4% | 0.5132259 |
| organic substance catabolic process | 9 out of 42 genes, 21.4% | 111 out of 533 genes, 20.8% | 0.525784 |
| positive regulation of phosphorus metabolic process | 2 out of 42 genes, 4.8% | 22 out of 533 genes, 4.1% | 0.5307627 |
| positive regulation of phosphate metabolic process | 2 out of 42 genes, 4.8% | 22 out of 533 genes, 4.1% | 0.5307627 |
| cellular component assembly | 6 out of 42 genes, 14.3% | 74 out of 533 genes, 13.9% | 0.5422187 |
| positive regulation of protein metabolic process | 3 out of 42 genes, 7.1% | 36 out of 533 genes, 6.8% | 0.5539219 |
| response to wounding | 2 out of 42 genes, 4.8% | 23 out of 533 genes, 4.3% | 0.5557181 |
| cell cycle phase | 2 out of 42 genes, 4.8% | 23 out of 533 genes, 4.3% | 0.5557181 |
| cellular biosynthetic process | 9 out of 42 genes, 21.4% | 114 out of 533 genes, 21.4% | 0.5627414 |
| nucleic acid metabolic process | 9 out of 42 genes, 21.4% | 114 out of 533 genes, 21.4% | 0.5627414 |
| macromolecular complex assembly | 4 out of 42 genes, 9.5% | 50 out of 533 genes, 9.4% | 0.5711972 |
| cellular component biogenesis | 7 out of 42 genes, 16.7% | 89 out of 533 genes, 16.7% | 0.5718714 |
| positive regulation of response to stimulus | 3 out of 42 genes, 7.1% | 37 out of 533 genes, 6.9% | 0.5735507 |
| mitotic cell cycle | 2 out of 42 genes, 4.8% | 24 out of 533 genes, 4.5% | 0.5797616 |
| system development | 4 out of 42 genes, 9.5% | 51 out of 533 genes, 9.6% | 0.5879715 |
| cellular localization | 7 out of 42 genes, 16.7% | 91 out of 533 genes, 17.1% | 0.598106 |
| carbohydrate metabolic process | 2 out of 42 genes, 4.8% | 25 out of 533 genes, 4.7% | 0.6028789 |
| response to DNA damage stimulus | 2 out of 42 genes, 4.8% | 25 out of 533 genes, 4.7% | 0.6028789 |
| ribonucleoprotein complex biogenesis | 2 out of 42 genes, 4.8% | 25 out of 533 genes, 4.7% | 0.6028789 |
| regulation of cell cycle | 2 out of 42 genes, 4.8% | 25 out of 533 genes, 4.7% | 0.6028789 |
| regulation of localization | 4 out of 42 genes, 9.5% | 52 out of 533 genes, 9.8% | 0.6043891 |
| organic substance biosynthetic process | 9 out of 42 genes, 21.4% | 118 out of 533 genes, 22.1% | 0.6104004 |
| protein metabolic process | 12 out of 42 genes, 28.6% | 158 out of 533 genes, 29.6% | 0.623882 |
| regulation of immune system process | 2 out of 42 genes, 4.8% | 26 out of 533 genes, 4.9% | 0.6250632 |
| biosynthetic process | 9 out of 42 genes, 21.4% | 120 out of 533 genes, 22.5% | 0.6333795 |
| gene expression | 8 out of 42 genes, 19.0% | 107 out of 533 genes, 20.1% | 0.6342685 |
| developmental process | 7 out of 42 genes, 16.7% | 94 out of 533 genes, 17.6% | 0.6360494 |
| regulation of cellular process | 19 out of 42 genes, 45.2% | 249 out of 533 genes, 46.7% | 0.639847 |
| chromosome organization | 2 out of 42 genes, 4.8% | 27 out of 533 genes, 5.1% | 0.6463147 |
| regulation of phosphate metabolic process | 3 out of 42 genes, 7.1% | 42 out of 533 genes, 7.9% | 0.6637406 |
| regulation of phosphorus metabolic process | 3 out of 42 genes, 7.1% | 42 out of 533 genes, 7.9% | 0.6637406 |
| positive regulation of protein modification process | 2 out of 42 genes, 4.8% | 28 out of 533 genes, 5.3% | 0.666639 |
| regulation of phosphorylation | 2 out of 42 genes, 4.8% | 28 out of 533 genes, 5.3% | 0.666639 |
| positive regulation of molecular function | 3 out of 42 genes, 7.1% | 43 out of 533 genes, 8.1% | 0.6801101 |
| protein complex assembly | 2 out of 42 genes, 4.8% | 29 out of 533 genes, 5.4% | 0.6860465 |
| regulation of biological process | 20 out of 42 genes, 47.6% | 267 out of 533 genes, 50.1% | 0.6894792 |
| regulation of signal transduction | 4 out of 42 genes, 9.5% | 58 out of 533 genes, 10.9% | 0.6947272 |
| cellular macromolecular complex assembly | 2 out of 42 genes, 4.8% | 30 out of 533 genes, 5.6% | 0.7045519 |
| protein complex biogenesis | 2 out of 42 genes, 4.8% | 30 out of 533 genes, 5.6% | 0.7045519 |
| regulation of protein metabolic process | 4 out of 42 genes, 9.5% | 61 out of 533 genes, 11.4% | 0.7343292 |
| protein catabolic process | 2 out of 42 genes, 4.8% | 32 out of 533 genes, 6.0% | 0.7389307 |
| positive regulation of cellular protein metabolic process | 2 out of 42 genes, 4.8% | 32 out of 533 genes, 6.0% | 0.7389307 |
| cellular response to chemical stimulus | 3 out of 42 genes, 7.1% | 48 out of 533 genes, 9.0% | 0.7534721 |
| purine nucleoside catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| nucleoside triphosphate catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| purine nucleoside triphosphate catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| nucleoside catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| ribonucleoside triphosphate catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| purine ribonucleoside triphosphate catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| cell cycle process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| ribonucleoside catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| purine ribonucleoside catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| glycosyl compound catabolic process | 2 out of 42 genes, 4.8% | 33 out of 533 genes, 6.2% | 0.7548478 |
| RNA processing | 3 out of 42 genes, 7.1% | 49 out of 533 genes, 9.2% | 0.7664758 |
| purine nucleotide catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| DNA metabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| purine ribonucleotide catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| nucleotide catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| ribonucleotide catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| organophosphate catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| purine-containing compound catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| nucleoside phosphate catabolic process | 2 out of 42 genes, 4.8% | 34 out of 533 genes, 6.4% | 0.7699492 |
| cell communication | 7 out of 42 genes, 16.7% | 107 out of 533 genes, 20.1% | 0.7766084 |
| regulation of cell death | 2 out of 42 genes, 4.8% | 35 out of 533 genes, 6.6% | 0.784261 |
| regulation of protein modification process | 2 out of 42 genes, 4.8% | 35 out of 533 genes, 6.6% | 0.784261 |
| regulation of apoptotic process | 2 out of 42 genes, 4.8% | 35 out of 533 genes, 6.6% | 0.784261 |
| regulation of programmed cell death | 2 out of 42 genes, 4.8% | 35 out of 533 genes, 6.6% | 0.784261 |
| carbohydrate derivative catabolic process | 2 out of 42 genes, 4.8% | 35 out of 533 genes, 6.6% | 0.784261 |
| organic cyclic compound metabolic process | 12 out of 42 genes, 28.6% | 176 out of 533 genes, 33.0% | 0.7891511 |
| regulation of cellular protein metabolic process | 3 out of 42 genes, 7.1% | 51 out of 533 genes, 9.6% | 0.7908759 |
| regulation of cell communication | 4 out of 42 genes, 9.5% | 66 out of 533 genes, 12.4% | 0.7919597 |
| regulation of transport | 2 out of 42 genes, 4.8% | 36 out of 533 genes, 6.8% | 0.7978104 |
| regulation of signaling | 4 out of 42 genes, 9.5% | 67 out of 533 genes, 12.6% | 0.8022584 |
| regulation of catalytic activity | 3 out of 42 genes, 7.1% | 52 out of 533 genes, 9.8% | 0.8022935 |
| positive regulation of cellular metabolic process | 4 out of 42 genes, 9.5% | 69 out of 533 genes, 12.9% | 0.8216734 |
| immune system process | 2 out of 42 genes, 4.8% | 38 out of 533 genes, 7.1% | 0.8227338 |
| signal transduction | 6 out of 42 genes, 14.3% | 99 out of 533 genes, 18.6% | 0.8285772 |
| positive regulation of macromolecule metabolic process | 4 out of 42 genes, 9.5% | 70 out of 533 genes, 13.1% | 0.8308041 |
| purine nucleoside triphosphate metabolic process | 2 out of 42 genes, 4.8% | 39 out of 533 genes, 7.3% | 0.8341648 |
| purine ribonucleoside triphosphate metabolic process | 2 out of 42 genes, 4.8% | 39 out of 533 genes, 7.3% | 0.8341648 |
| cellular response to organic substance | 2 out of 42 genes, 4.8% | 39 out of 533 genes, 7.3% | 0.8341648 |
| multicellular organismal development | 4 out of 42 genes, 9.5% | 71 out of 533 genes, 13.3% | 0.8395607 |
| cell cycle | 2 out of 42 genes, 4.8% | 40 out of 533 genes, 7.5% | 0.8449467 |
| ribonucleoside triphosphate metabolic process | 2 out of 42 genes, 4.8% | 40 out of 533 genes, 7.5% | 0.8449467 |
| purine nucleoside metabolic process | 2 out of 42 genes, 4.8% | 40 out of 533 genes, 7.5% | 0.8449467 |
| purine ribonucleoside metabolic process | 2 out of 42 genes, 4.8% | 40 out of 533 genes, 7.5% | 0.8449467 |
| organonitrogen compound catabolic process | 2 out of 42 genes, 4.8% | 40 out of 533 genes, 7.5% | 0.8449467 |
| nucleoside triphosphate metabolic process | 2 out of 42 genes, 4.8% | 41 out of 533 genes, 7.7% | 0.8551078 |
| signaling | 6 out of 42 genes, 14.3% | 103 out of 533 genes, 19.3% | 0.8582383 |
| single organism signaling | 6 out of 42 genes, 14.3% | 103 out of 533 genes, 19.3% | 0.8582383 |
| proteolysis | 2 out of 42 genes, 4.8% | 42 out of 533 genes, 7.9% | 0.8646761 |
| ribonucleoside metabolic process | 2 out of 42 genes, 4.8% | 42 out of 533 genes, 7.9% | 0.8646761 |
| positive regulation of metabolic process | 4 out of 42 genes, 9.5% | 75 out of 533 genes, 14.1% | 0.8710194 |
| purine nucleotide metabolic process | 2 out of 42 genes, 4.8% | 43 out of 533 genes, 8.1% | 0.8736793 |
| nucleoside metabolic process | 2 out of 42 genes, 4.8% | 43 out of 533 genes, 8.1% | 0.8736793 |
| purine ribonucleotide metabolic process | 2 out of 42 genes, 4.8% | 43 out of 533 genes, 8.1% | 0.8736793 |
| positive regulation of macromolecule biosynthetic process | 2 out of 42 genes, 4.8% | 43 out of 533 genes, 8.1% | 0.8736793 |
| purine-containing compound metabolic process | 2 out of 42 genes, 4.8% | 43 out of 533 genes, 8.1% | 0.8736793 |
| glycosyl compound metabolic process | 2 out of 42 genes, 4.8% | 43 out of 533 genes, 8.1% | 0.8736793 |
| macromolecule metabolic process | 15 out of 42 genes, 35.7% | 229 out of 533 genes, 43.0% | 0.8757651 |
| ribonucleotide metabolic process | 2 out of 42 genes, 4.8% | 44 out of 533 genes, 8.3% | 0.8821445 |
| ribose phosphate metabolic process | 2 out of 42 genes, 4.8% | 44 out of 533 genes, 8.3% | 0.8821445 |
| multicellular organismal process | 5 out of 42 genes, 11.9% | 93 out of 533 genes, 17.4% | 0.8889992 |
| nucleobase-containing compound metabolic process | 10 out of 42 genes, 23.8% | 165 out of 533 genes, 31.0% | 0.8904629 |
| positive regulation of cellular biosynthetic process | 2 out of 42 genes, 4.8% | 46 out of 533 genes, 8.6% | 0.8975654 |
| positive regulation of biosynthetic process | 2 out of 42 genes, 4.8% | 47 out of 533 genes, 8.8% | 0.9045718 |
| cellular aromatic compound metabolic process | 10 out of 42 genes, 23.8% | 169 out of 533 genes, 31.7% | 0.9091044 |
| heterocycle metabolic process | 10 out of 42 genes, 23.8% | 170 out of 533 genes, 31.9% | 0.9133528 |
| single-organism metabolic process | 6 out of 42 genes, 14.3% | 113 out of 533 genes, 21.2% | 0.9150075 |
| regulation of molecular function | 3 out of 42 genes, 7.1% | 66 out of 533 genes, 12.4% | 0.9152802 |
| cellular protein metabolic process | 8 out of 42 genes, 19.0% | 143 out of 533 genes, 26.8% | 0.9182748 |
| negative regulation of cellular process | 5 out of 42 genes, 11.9% | 99 out of 533 genes, 18.6% | 0.9203062 |
| nucleoside phosphate metabolic process | 2 out of 42 genes, 4.8% | 51 out of 533 genes, 9.6% | 0.9284576 |
| nucleotide metabolic process | 2 out of 42 genes, 4.8% | 51 out of 533 genes, 9.6% | 0.9284576 |
| carbohydrate derivative metabolic process | 2 out of 42 genes, 4.8% | 51 out of 533 genes, 9.6% | 0.9284576 |
| cellular nitrogen compound metabolic process | 10 out of 42 genes, 23.8% | 174 out of 533 genes, 32.6% | 0.9288025 |
| organophosphate metabolic process | 2 out of 42 genes, 4.8% | 53 out of 533 genes, 9.9% | 0.9382217 |
| single-multicellular organism process | 4 out of 42 genes, 9.5% | 88 out of 533 genes, 16.5% | 0.9401853 |
| regulation of primary metabolic process | 8 out of 42 genes, 19.0% | 150 out of 533 genes, 28.1% | 0.9433925 |
| nucleobase-containing small molecule metabolic process | 2 out of 42 genes, 4.8% | 55 out of 533 genes, 10.3% | 0.9467452 |
| negative regulation of biological process | 5 out of 42 genes, 11.9% | 107 out of 533 genes, 20.1% | 0.9501889 |
| nitrogen compound metabolic process | 10 out of 42 genes, 23.8% | 181 out of 533 genes, 34.0% | 0.9504576 |
| regulation of biosynthetic process | 5 out of 42 genes, 11.9% | 108 out of 533 genes, 20.3% | 0.9531337 |
| primary metabolic process | 19 out of 42 genes, 45.2% | 304 out of 533 genes, 57.0% | 0.9611626 |
| small molecule metabolic process | 4 out of 42 genes, 9.5% | 95 out of 533 genes, 17.8% | 0.9618059 |
| cellular macromolecule metabolic process | 12 out of 42 genes, 28.6% | 216 out of 533 genes, 40.5% | 0.9668678 |
| regulation of cellular metabolic process | 7 out of 42 genes, 16.7% | 148 out of 533 genes, 27.8% | 0.9730515 |
| organic substance metabolic process | 19 out of 42 genes, 45.2% | 311 out of 533 genes, 58.3% | 0.974217 |
| regulation of metabolic process | 8 out of 42 genes, 19.0% | 166 out of 533 genes, 31.1% | 0.9776376 |
| regulation of macromolecule biosynthetic process | 4 out of 42 genes, 9.5% | 103 out of 533 genes, 19.3% | 0.9777531 |
| regulation of cellular biosynthetic process | 4 out of 42 genes, 9.5% | 105 out of 533 genes, 19.7% | 0.9806518 |
| organonitrogen compound metabolic process | 2 out of 42 genes, 4.8% | 69 out of 533 genes, 12.9% | 0.9819862 |
| metabolic process | 19 out of 42 genes, 45.2% | 321 out of 533 genes, 60.2% | 0.9864464 |
| cellular metabolic process | 17 out of 42 genes, 40.5% | 297 out of 533 genes, 55.7% | 0.9870803 |
| regulation of macromolecule metabolic process | 6 out of 42 genes, 14.3% | 146 out of 533 genes, 27.4% | 0.9888934 |
| phosphorus metabolic process | 2 out of 42 genes, 4.8% | 75 out of 533 genes, 14.1% | 0.9889286 |
| phosphate-containing compound metabolic process | 2 out of 42 genes, 4.8% | 75 out of 533 genes, 14.1% | 0.9889286 |
| regulation of nitrogen compound metabolic process | 4 out of 42 genes, 9.5% | 115 out of 533 genes, 21.6% | 0.9906202 |
| regulation of cellular macromolecule biosynthetic process | 3 out of 42 genes, 7.1% | 99 out of 533 genes, 18.6% | 0.9920838 |
| regulation of transcription, DNA-dependent | 2 out of 42 genes, 4.8% | 82 out of 533 genes, 15.4% | 0.9938237 |
| regulation of RNA biosynthetic process | 2 out of 42 genes, 4.8% | 84 out of 533 genes, 15.8% | 0.9947882 |
| regulation of nucleobase-containing compound metabolic process | 3 out of 42 genes, 7.1% | 111 out of 533 genes, 20.8% | 0.9970061 |
| regulation of RNA metabolic process | 2 out of 42 genes, 4.8% | 92 out of 533 genes, 17.3% | 0.997392 |
| regulation of gene expression | 3 out of 42 genes, 7.1% | 116 out of 533 genes, 21.8% | 0.9980353 |
| Gene Ontology term | Genes annotated to the term |
|---|
| muscle organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| myofibril assembly | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000002381 |
| single-organism process | ENSAPLP00000009762, ENSAPLP00000010816, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000010466, ENSAPLP00000014857, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000011711, ENSAPLP00000015706, ENSAPLP00000003219, ENSAPLP00000009009, ENSAPLP00000006508, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000015793, ENSAPLP00000004050, ENSAPLP00000008210, ENSAPLP00000001783, ENSAPLP00000015679, ENSAPLP00000008550, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000015167, ENSAPLP00000013412, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000009282, ENSAPLP00000002020 |
| muscle system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| skeletal muscle thin filament assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiocyte differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| single-organism cellular process | ENSAPLP00000009762, ENSAPLP00000010816, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000010466, ENSAPLP00000014857, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000015706, ENSAPLP00000003219, ENSAPLP00000009009, ENSAPLP00000006508, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000015793, ENSAPLP00000004050, ENSAPLP00000008210, ENSAPLP00000001783, ENSAPLP00000015679, ENSAPLP00000008550, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000010949, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000009282, ENSAPLP00000002020 |
| muscle structure development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000002381 |
| muscle organ development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based movement | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular component organization | ENSAPLP00000009762, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000015793, ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007620 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| striated muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of anatomical structure size | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050, ENSAPLP00000002381 |
| response to temperature stimulus | ENSAPLP00000000447, ENSAPLP00000004050 |
| response to heat | ENSAPLP00000000447, ENSAPLP00000004050 |
| muscle filament sliding | ENSAPLP00000003657, ENSAPLP00000003219 |
| lipoprotein metabolic process | ENSAPLP00000011529, ENSAPLP00000002020 |
| skeletal muscle fiber development | ENSAPLP00000003657, ENSAPLP00000002381 |
| muscle fiber development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cellular component organization or biogenesis | ENSAPLP00000009762, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000015793, ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007620 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| cell adhesion | ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000003689, ENSAPLP00000006049 |
| biological adhesion | ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000003689, ENSAPLP00000006049 |
| heart development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular process involved in reproduction | ENSAPLP00000010466, ENSAPLP00000008550, ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000008397, ENSAPLP00000015793 |
| skeletal muscle tissue development | ENSAPLP00000003657, ENSAPLP00000002381 |
| ribosomal small subunit biogenesis | ENSAPLP00000015617, ENSAPLP00000015793 |
| skeletal muscle organ development | ENSAPLP00000003657, ENSAPLP00000002381 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| regulation of actin filament length | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| tissue development | ENSAPLP00000003657, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of biological quality | ENSAPLP00000001720, ENSAPLP00000002296, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000010639, ENSAPLP00000015679, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000002381 |
| protein targeting to membrane | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| macromolecule localization | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009009, ENSAPLP00000002020 |
| cellular component movement | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000002296, ENSAPLP00000004050, ENSAPLP00000002381 |
| extracellular matrix organization | ENSAPLP00000003223, ENSAPLP00000003689, ENSAPLP00000006049 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| regulation of actin filament-based process | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| extracellular structure organization | ENSAPLP00000003223, ENSAPLP00000003689, ENSAPLP00000006049 |
| organic substance transport | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009009, ENSAPLP00000002020 |
| regulation of muscle contraction | ENSAPLP00000003219, ENSAPLP00000013090 |
| actin filament organization | ENSAPLP00000003657, ENSAPLP00000002381 |
| steroid metabolic process | ENSAPLP00000010639, ENSAPLP00000002020 |
| response to extracellular stimulus | ENSAPLP00000003657, ENSAPLP00000009762 |
| cell growth | ENSAPLP00000003657, ENSAPLP00000008550 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000002296 |
| response to stimulus | ENSAPLP00000006508, ENSAPLP00000009762, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000002381, ENSAPLP00000008717, ENSAPLP00000003657, ENSAPLP00000015167, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000010949, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000013090, ENSAPLP00000015706, ENSAPLP00000000447, ENSAPLP00000003219 |
| cellular component disassembly | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000008397, ENSAPLP00000015793 |
| regulation of cellular component size | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| cell development | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| ATP catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| lipid transport | ENSAPLP00000011529, ENSAPLP00000002020 |
| response to virus | ENSAPLP00000008550, ENSAPLP00000002381 |
| lipid localization | ENSAPLP00000011529, ENSAPLP00000002020 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of muscle system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| translational termination | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| response to abiotic stimulus | ENSAPLP00000003657, ENSAPLP00000000447, ENSAPLP00000005411, ENSAPLP00000004050 |
| viral genome expression | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| viral transcription | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| nucleocytoplasmic transport | ENSAPLP00000010466, ENSAPLP00000015617, ENSAPLP00000009009 |
| organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| nuclear transport | ENSAPLP00000010466, ENSAPLP00000015617, ENSAPLP00000009009 |
| protein complex disassembly | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| cellular protein complex disassembly | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| localization | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000004050, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000008550, ENSAPLP00000015679, ENSAPLP00000003223, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009009, ENSAPLP00000002020 |
| response to organic cyclic compound | ENSAPLP00000003657, ENSAPLP00000008717, ENSAPLP00000010949 |
| cardiovascular system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| protein complex subunit organization | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000002381 |
| macromolecular complex subunit organization | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000001783, ENSAPLP00000008550, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000002381 |
| protein transport | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009009 |
| viral infectious cycle | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| macromolecular complex disassembly | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| response to steroid hormone stimulus | ENSAPLP00000003657, ENSAPLP00000008717 |
| organelle assembly | ENSAPLP00000015617, ENSAPLP00000009762 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| single-organism transport | ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009009, ENSAPLP00000002020 |
| establishment of protein localization | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009009 |
| protein localization | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009009 |
| actin cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cotranslational protein targeting to membrane | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| response to external stimulus | ENSAPLP00000003657, ENSAPLP00000009762, ENSAPLP00000004050, ENSAPLP00000013090 |
| protein targeting to ER | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| protein localization to endoplasmic reticulum | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| multi-organism process | ENSAPLP00000010466, ENSAPLP00000008550, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000002381, ENSAPLP00000015706 |
| regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| cellular component morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| growth | ENSAPLP00000003657, ENSAPLP00000008550 |
| monosaccharide catabolic process | ENSAPLP00000006919, ENSAPLP00000009741 |
| nuclear export | ENSAPLP00000015617, ENSAPLP00000009009 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| nucleic acid phosphodiester bond hydrolysis | ENSAPLP00000015617, ENSAPLP00000010949 |
| transport | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000008550, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009009, ENSAPLP00000002020 |
| reproduction | ENSAPLP00000010466, ENSAPLP00000008550, ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015793 |
| establishment of localization | ENSAPLP00000006508, ENSAPLP00000010466, ENSAPLP00000013412, ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000008550, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009009, ENSAPLP00000002020 |
| cell differentiation | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000013090, ENSAPLP00000002381 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| carbohydrate catabolic process | ENSAPLP00000006919, ENSAPLP00000009741 |
| regulation of Wnt receptor signaling pathway | ENSAPLP00000004471, ENSAPLP00000009282 |
| regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| response to lipid | ENSAPLP00000003657, ENSAPLP00000008717 |
| single-organism carbohydrate catabolic process | ENSAPLP00000006919, ENSAPLP00000009741 |
| ATP metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| response to other organism | ENSAPLP00000008550, ENSAPLP00000002381 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| establishment of protein localization to organelle | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| RNA biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| RNA catabolic process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| mRNA catabolic process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| translational initiation | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| actin filament-based process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| response to biotic stimulus | ENSAPLP00000008550, ENSAPLP00000002381 |
| positive regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000002296 |
| regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000009282 |
| protein targeting | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| cytoplasmic transport | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793 |
| reproductive process | ENSAPLP00000010466, ENSAPLP00000008550, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015793 |
| cellular developmental process | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000013090, ENSAPLP00000002381 |
| cellular response to stress | ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000009762, ENSAPLP00000015706 |
| intracellular protein transport | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| rRNA processing | ENSAPLP00000015617, ENSAPLP00000015793 |
| rRNA metabolic process | ENSAPLP00000015617, ENSAPLP00000015793 |
| sexual reproduction | ENSAPLP00000008550, ENSAPLP00000011529 |
| positive regulation of multicellular organismal process | ENSAPLP00000003219, ENSAPLP00000004050 |
| DNA conformation change | ENSAPLP00000010949, ENSAPLP00000001720 |
| cellular process | ENSAPLP00000009762, ENSAPLP00000010816, ENSAPLP00000010639, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000003943, ENSAPLP00000010466, ENSAPLP00000014857, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000003219, ENSAPLP00000009009, ENSAPLP00000006508, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000015793, ENSAPLP00000004050, ENSAPLP00000008210, ENSAPLP00000001783, ENSAPLP00000015679, ENSAPLP00000008550, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000013412, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000003223, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000009282, ENSAPLP00000009741, ENSAPLP00000002020 |
| lipid metabolic process | ENSAPLP00000010639, ENSAPLP00000011529, ENSAPLP00000002020 |
| viral reproduction | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| multi-organism cellular process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| response to stress | ENSAPLP00000015167, ENSAPLP00000000447, ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000009762, ENSAPLP00000004050, ENSAPLP00000015706 |
| positive regulation of developmental process | ENSAPLP00000011529, ENSAPLP00000009282 |
| regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050 |
| single organism reproductive process | ENSAPLP00000008550, ENSAPLP00000011529 |
| organelle organization | ENSAPLP00000003657, ENSAPLP00000013412, ENSAPLP00000001720, ENSAPLP00000009762, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000015617, ENSAPLP00000002381 |
| regulation of cellular component organization | ENSAPLP00000013412, ENSAPLP00000003219, ENSAPLP00000002296, ENSAPLP00000004050, ENSAPLP00000013090 |
| small GTPase mediated signal transduction | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000014857 |
| regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000009282 |
| protein localization to organelle | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| translational elongation | ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000015793 |
| cellular protein localization | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| cellular macromolecule localization | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| viral reproductive process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| regulation of developmental process | ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000009282, ENSAPLP00000013090 |
| response to chemical stimulus | ENSAPLP00000003657, ENSAPLP00000008717, ENSAPLP00000001783, ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000013090 |
| monosaccharide metabolic process | ENSAPLP00000006919, ENSAPLP00000009741 |
| regulation of cell migration | ENSAPLP00000003219, ENSAPLP00000005411 |
| ncRNA processing | ENSAPLP00000015617, ENSAPLP00000015793 |
| regulation of locomotion | ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| negative regulation of cellular component organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of cell motility | ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of multicellular organismal process | ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000013090 |
| cellular response to stimulus | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000010949, ENSAPLP00000014857, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000009762, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000015706, ENSAPLP00000001783, ENSAPLP00000003219 |
| multi-organism reproductive process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| intracellular signal transduction | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000001720, ENSAPLP00000015706 |
| cell projection organization | ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000013090 |
| response to oxygen-containing compound | ENSAPLP00000003657, ENSAPLP00000001783, ENSAPLP00000003219 |
| organic cyclic compound biosynthetic process | ENSAPLP00000010639, ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| anatomical structure development | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000013090, ENSAPLP00000002381 |
| response to hormone stimulus | ENSAPLP00000003657, ENSAPLP00000008717 |
| cell motility | ENSAPLP00000011529, ENSAPLP00000004050 |
| regulation of cellular component movement | ENSAPLP00000003219, ENSAPLP00000005411 |
| localization of cell | ENSAPLP00000011529, ENSAPLP00000004050 |
| anatomical structure morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| translation | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015793 |
| macromolecule catabolic process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| response to endogenous stimulus | ENSAPLP00000003657, ENSAPLP00000008717, ENSAPLP00000001783 |
| locomotion | ENSAPLP00000011529, ENSAPLP00000004050, ENSAPLP00000013090 |
| RNA metabolic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| apoptotic process | ENSAPLP00000003657, ENSAPLP00000002381 |
| chemotaxis | ENSAPLP00000004050, ENSAPLP00000013090 |
| programmed cell death | ENSAPLP00000003657, ENSAPLP00000002381 |
| taxis | ENSAPLP00000004050, ENSAPLP00000013090 |
| regulation of cellular component biogenesis | ENSAPLP00000003219, ENSAPLP00000004050 |
| chemical homeostasis | ENSAPLP00000015679, ENSAPLP00000011529 |
| single-organism developmental process | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000013090, ENSAPLP00000002381 |
| response to organic substance | ENSAPLP00000003657, ENSAPLP00000008717, ENSAPLP00000001783, ENSAPLP00000010949, ENSAPLP00000004050 |
| intracellular transport | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000006919, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009741 |
| mRNA metabolic process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| nucleobase-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| protein folding | ENSAPLP00000003943, ENSAPLP00000009009 |
| cell death | ENSAPLP00000003657, ENSAPLP00000002381 |
| death | ENSAPLP00000003657, ENSAPLP00000002381 |
| ribosome biogenesis | ENSAPLP00000015617, ENSAPLP00000015793 |
| positive regulation of cellular component organization | ENSAPLP00000003219, ENSAPLP00000002296 |
| homeostatic process | ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000001720 |
| positive regulation of biological process | ENSAPLP00000015167, ENSAPLP00000005411, ENSAPLP00000002296, ENSAPLP00000004050, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529, ENSAPLP00000009282 |
| macromolecule biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015793 |
| cellular macromolecule biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015793 |
| biological regulation | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000010639, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000015167, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000010949, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000015706, ENSAPLP00000004471, ENSAPLP00000005466, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000009282 |
| cellular catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000006919, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000015706 |
| aromatic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| organ development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| single-organism carbohydrate metabolic process | ENSAPLP00000006919, ENSAPLP00000009741 |
| cellular response to oxygen-containing compound | ENSAPLP00000001783, ENSAPLP00000003219 |
| positive regulation of cellular process | ENSAPLP00000005411, ENSAPLP00000002296, ENSAPLP00000004050, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529, ENSAPLP00000009282 |
| establishment of localization in cell | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| positive regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000009282 |
| response to nitrogen compound | ENSAPLP00000001783, ENSAPLP00000010949 |
| cellular nitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| heterocycle catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| organic cyclic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| aromatic compound biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| regulation of response to stimulus | ENSAPLP00000004471, ENSAPLP00000015167, ENSAPLP00000005411, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000006049 |
| ncRNA metabolic process | ENSAPLP00000015617, ENSAPLP00000015793 |
| heterocycle biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| cellular macromolecule catabolic process | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000008397, ENSAPLP00000015793 |
| positive regulation of catalytic activity | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000015706 |
| organic substance catabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000006919, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009741 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000009282 |
| positive regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000009282 |
| cellular component assembly | ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000009762 |
| positive regulation of protein metabolic process | ENSAPLP00000000447, ENSAPLP00000004050, ENSAPLP00000015706 |
| response to wounding | ENSAPLP00000015167, ENSAPLP00000003219 |
| cell cycle phase | ENSAPLP00000000447, ENSAPLP00000015706 |
| cellular biosynthetic process | ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000010639, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529 |
| nucleic acid metabolic process | ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000015617, ENSAPLP00000007620 |
| macromolecular complex assembly | ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000001720 |
| cellular component biogenesis | ENSAPLP00000008550, ENSAPLP00000001783, ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000009762, ENSAPLP00000015793 |
| positive regulation of response to stimulus | ENSAPLP00000015167, ENSAPLP00000005411, ENSAPLP00000009282 |
| mitotic cell cycle | ENSAPLP00000000447, ENSAPLP00000015706 |
| system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| cellular localization | ENSAPLP00000010466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000013090 |
| carbohydrate metabolic process | ENSAPLP00000006919, ENSAPLP00000009741 |
| response to DNA damage stimulus | ENSAPLP00000010949, ENSAPLP00000015706 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000015617, ENSAPLP00000015793 |
| regulation of cell cycle | ENSAPLP00000000447, ENSAPLP00000015706 |
| regulation of localization | ENSAPLP00000013412, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411 |
| organic substance biosynthetic process | ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000010639, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529 |
| protein metabolic process | ENSAPLP00000015167, ENSAPLP00000003943, ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000011529, ENSAPLP00000002020 |
| regulation of immune system process | ENSAPLP00000015167, ENSAPLP00000001720 |
| biosynthetic process | ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000010639, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529 |
| gene expression | ENSAPLP00000010466, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706 |
| developmental process | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000013090, ENSAPLP00000002381 |
| regulation of cellular process | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000014857, ENSAPLP00000010949, ENSAPLP00000013412, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000015706, ENSAPLP00000004471, ENSAPLP00000005466, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000009282 |
| chromosome organization | ENSAPLP00000000447, ENSAPLP00000001720 |
| regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000009282 |
| regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000009282 |
| positive regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000015706 |
| regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000009282 |
| positive regulation of molecular function | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000015706 |
| protein complex assembly | ENSAPLP00000008550, ENSAPLP00000001783 |
| regulation of biological process | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000015167, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000010949, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000002296, ENSAPLP00000013090, ENSAPLP00000015706, ENSAPLP00000004471, ENSAPLP00000005466, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000009282 |
| regulation of signal transduction | ENSAPLP00000004471, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000006049 |
| cellular macromolecular complex assembly | ENSAPLP00000015617, ENSAPLP00000001720 |
| protein complex biogenesis | ENSAPLP00000008550, ENSAPLP00000001783 |
| regulation of protein metabolic process | ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000004050, ENSAPLP00000015706 |
| protein catabolic process | ENSAPLP00000011529, ENSAPLP00000015706 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000015706 |
| cellular response to chemical stimulus | ENSAPLP00000001783, ENSAPLP00000003219, ENSAPLP00000004050 |
| purine nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| cell cycle process | ENSAPLP00000000447, ENSAPLP00000015706 |
| ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| glycosyl compound catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| RNA processing | ENSAPLP00000015617, ENSAPLP00000010949, ENSAPLP00000015793 |
| purine nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| DNA metabolic process | ENSAPLP00000010949, ENSAPLP00000001720 |
| purine ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| organophosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleoside phosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| cell communication | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000001720, ENSAPLP00000009762, ENSAPLP00000010816, ENSAPLP00000015706 |
| regulation of cell death | ENSAPLP00000004050, ENSAPLP00000015706 |
| regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000015706 |
| regulation of apoptotic process | ENSAPLP00000004050, ENSAPLP00000015706 |
| regulation of programmed cell death | ENSAPLP00000004050, ENSAPLP00000015706 |
| carbohydrate derivative catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| organic cyclic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000010639, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000002020 |
| regulation of cellular protein metabolic process | ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000015706 |
| regulation of cell communication | ENSAPLP00000004471, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000006049 |
| regulation of transport | ENSAPLP00000013412, ENSAPLP00000005411 |
| regulation of signaling | ENSAPLP00000004471, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000006049 |
| regulation of catalytic activity | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000015706 |
| positive regulation of cellular metabolic process | ENSAPLP00000000447, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| immune system process | ENSAPLP00000015167, ENSAPLP00000015706 |
| signal transduction | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000001720, ENSAPLP00000010816, ENSAPLP00000015706 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000000447, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| cellular response to organic substance | ENSAPLP00000001783, ENSAPLP00000004050 |
| multicellular organismal development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| cell cycle | ENSAPLP00000000447, ENSAPLP00000015706 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| organonitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| signaling | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000001720, ENSAPLP00000010816, ENSAPLP00000015706 |
| single organism signaling | ENSAPLP00000006508, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000001720, ENSAPLP00000010816, ENSAPLP00000015706 |
| proteolysis | ENSAPLP00000009762, ENSAPLP00000015706 |
| ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| positive regulation of metabolic process | ENSAPLP00000000447, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| purine nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| purine ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| positive regulation of macromolecule biosynthetic process | ENSAPLP00000009282, ENSAPLP00000004050 |
| purine-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| glycosyl compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| macromolecule metabolic process | ENSAPLP00000015167, ENSAPLP00000003943, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000011529, ENSAPLP00000002020 |
| ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| ribose phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| multicellular organismal process | ENSAPLP00000003657, ENSAPLP00000008550, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| nucleobase-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000015617, ENSAPLP00000007620 |
| positive regulation of cellular biosynthetic process | ENSAPLP00000009282, ENSAPLP00000004050 |
| positive regulation of biosynthetic process | ENSAPLP00000009282, ENSAPLP00000004050 |
| cellular aromatic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000015617, ENSAPLP00000007620 |
| heterocycle metabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000015617, ENSAPLP00000007620 |
| single-organism metabolic process | ENSAPLP00000003657, ENSAPLP00000010639, ENSAPLP00000006919, ENSAPLP00000011529, ENSAPLP00000002020, ENSAPLP00000015706 |
| regulation of molecular function | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000015706 |
| cellular protein metabolic process | ENSAPLP00000003943, ENSAPLP00000010466, ENSAPLP00000008397, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009009 |
| negative regulation of cellular process | ENSAPLP00000004471, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000004050, ENSAPLP00000015706 |
| nucleoside phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| carbohydrate derivative metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| cellular nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000015617, ENSAPLP00000007620 |
| organophosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| single-multicellular organism process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| regulation of primary metabolic process | ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| negative regulation of biological process | ENSAPLP00000004471, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000004050, ENSAPLP00000015706 |
| nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000015617, ENSAPLP00000007620 |
| regulation of biosynthetic process | ENSAPLP00000007620, ENSAPLP00000010949, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000004050 |
| primary metabolic process | ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000010639, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000003943, ENSAPLP00000015167, ENSAPLP00000010949, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000007620, ENSAPLP00000009009, ENSAPLP00000009741, ENSAPLP00000002020 |
| small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000006919, ENSAPLP00000002020, ENSAPLP00000015706 |
| cellular macromolecule metabolic process | ENSAPLP00000003943, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000009009, ENSAPLP00000011529 |
| regulation of cellular metabolic process | ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| organic substance metabolic process | ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000010639, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000003943, ENSAPLP00000015167, ENSAPLP00000010949, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000007620, ENSAPLP00000009009, ENSAPLP00000009741, ENSAPLP00000002020 |
| regulation of metabolic process | ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000007620, ENSAPLP00000010949, ENSAPLP00000009282, ENSAPLP00000004050 |
| regulation of cellular biosynthetic process | ENSAPLP00000007620, ENSAPLP00000010949, ENSAPLP00000009282, ENSAPLP00000004050 |
| organonitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| metabolic process | ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000010639, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000003657, ENSAPLP00000010466, ENSAPLP00000003943, ENSAPLP00000015167, ENSAPLP00000010949, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000015706, ENSAPLP00000005466, ENSAPLP00000006919, ENSAPLP00000007620, ENSAPLP00000009009, ENSAPLP00000009741, ENSAPLP00000002020 |
| cellular metabolic process | ENSAPLP00000003657, ENSAPLP00000003943, ENSAPLP00000010466, ENSAPLP00000010949, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000009762, ENSAPLP00000015793, ENSAPLP00000015706, ENSAPLP00000010639, ENSAPLP00000005466, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000006919, ENSAPLP00000009009, ENSAPLP00000011529, ENSAPLP00000009741 |
| regulation of macromolecule metabolic process | ENSAPLP00000007620, ENSAPLP00000000447, ENSAPLP00000010949, ENSAPLP00000009282, ENSAPLP00000004050, ENSAPLP00000015706 |
| phosphorus metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| phosphate-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015706 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000009282, ENSAPLP00000015706 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000007620, ENSAPLP00000010949, ENSAPLP00000009282 |
| regulation of transcription, DNA-dependent | ENSAPLP00000010949, ENSAPLP00000009282 |
| regulation of RNA biosynthetic process | ENSAPLP00000010949, ENSAPLP00000009282 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000010949, ENSAPLP00000003219, ENSAPLP00000009282 |
| regulation of RNA metabolic process | ENSAPLP00000010949, ENSAPLP00000009282 |
| regulation of gene expression | ENSAPLP00000007620, ENSAPLP00000010949, ENSAPLP00000009282 |
|